AION Diagnostics Announces Theodor Dingermann to Advisory Board

AION Diagnostics Inc., a nano-diagnostics company marketing agents for medical imaging, today announced the appointment of Theodor Dingermann, Ph.D. to its Scientific Advisory Board.

Professor Dingermann has over 30 years of experience in the pharmaceutical sector in Germany. E 'biotechnology consultant to the State of Hesse as well as Editor-in-chief of two major German pharmaceutical journals,' Die Pharmazie 'and' Pharmazie in unserer Zeit '.

'We are very pleased to expertise in the field of molecular biology and biochemistry Prof. Dingermann lead to AION, especially our platform for molecular imaging,' said AION President and CEO, Dr. Anna Kluczewsko.

Since 1990, Prof. Dingermann was Professor of Pharmaceutical Biology at Goethe University in Frankfurt, Germany. E 'Chairman of the Working Group and vice president of biopharmaceuticals for the pharmaceutical biology of the German Pharmacopeia Commission. From 2000 to 2004 was president of the German Pharmaceutical Society. Prof. Dingermann studied Pharmacy at the University of Erlangen, Germany. After obtaining his PhD in biochemistry, worked as a Post-Doctoral Research Fellow at Yale University, New Haven.

The AION Scientific Advisory Board is chartered to contribute independent scientific advice to the business of the Company.